Skip to main content
. 2021 Mar 13;9(3):256. doi: 10.3390/vaccines9030256

Table 3.

Variation (%) from 2015 to 2019 for the mean percentages of routine vaccination coverage in different regions of the World Health Organization.

Vaccine World African Region American Region Eastern
Mediterranean
Region
European Region South-East Asia Region Western
Pacific
Region
BCG −0.3 0.1 −5.0 −2.1 4.2 1.2 0.2
DTP1 −0.3 0 −3.0 0.2 0.6 1.7 −0.1
DTP3 0 1.2 −2.7 −0.2 0.8 1.2 −0.3
HepB1 3.2 −5.3 7.7 0.8 1.2 5.5 5.0
HepB3 0.3 1.6 −2.5 −0.2 1.3 1.2 −0.3
Hib3 0.9 1.6 −2.2 −0.2 2.2 6.4 −0.7
IPV1 28 140.5 75.6 11.9 3.3 94.9 14
MCV1 −0.1 −0.1 −1.8 0.2 0 2.8 0.3
MCV2 −2.0 0 −4.5 1.6 0.9 6.3 −6.0
PCV3 5 11.1 0.9 −4.3 5.5 97.5 8.3
Pol3 −0.2 0.5 −2.2 −0.2 0.4 1.8 −1.0
RCV1 −1.4 −5.4 −1.8 −0.2 0 −1.2 0.5
Rota 3.8 14.5 −3.5 −5.0 −8.3 41.5

BCG: Bacillus Calmette–Guérin vaccine against tuberculosis; DTP1: first dose of diphtheria-tetanus-pertussis vaccine; DTP3: third dose of diphtheria-tetanus-pertussis vaccine; HepB1: first dose of hepatitis B vaccine; HepB3: third dose of hepatitis B vaccine; Hib3: third dose of Haemophilus influenzae vaccine; IPV1: first dose of inactivated poliovirus vaccine; MCV1: first dose of measles-containing vaccine; MCV2: second dose of measles-containing vaccine; PCV3: third dose of pneumococcal conjugate vaccine; Pol3: third dose of polio vaccine; RCV1: first dose of rubella-containing vaccine; Rota: last dose of rotavirus vaccine.